These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8348561)

  • 1. Interleukin-5 induces tumor suppression by peritoneal exudate cells in mice.
    Nakashima Y; Mita S; Takatsu K; Ogawa M
    Cancer Immunol Immunother; 1993 Sep; 37(4):227-32. PubMed ID: 8348561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination treatment with irritant and recombinant interleukin 2 in the peritoneal cavity for evoking effective anti-tumor activity: generation of lymphokine-activated killer cells and tumor-specific killer cells.
    Uchida H; Taniguchi K; Nomoto K
    Jpn J Cancer Res; 1990 Apr; 81(4):416-24. PubMed ID: 2114394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice.
    Kato I; Yokokura T; Mutai M
    Cancer Immunol Immunother; 1988; 26(3):215-21. PubMed ID: 3133111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites.
    Micallef MJ; Yoshida K; Kawai S; Hanaya T; Kohno K; Arai S; Tanimoto T; Torigoe K; Fujii M; Ikeda M; Kurimoto M
    Cancer Immunol Immunother; 1997 Jan; 43(6):361-7. PubMed ID: 9067408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of murine antitumor activity by prothymosin alpha treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor alpha.
    Papanastasiou M; Baxevanis CN; Papamichail M
    Cancer Immunol Immunother; 1992; 35(2):145-50. PubMed ID: 1596938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide modifies the induction kinetics but not cell types and cytotoxic mechanisms of antitumor cells elicited with OK-432 plus attenuated tumor cells.
    Ryoyama K; Ryoyama C
    Cancer Immunol Immunother; 1991; 34(3):143-9. PubMed ID: 1756530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tumoricidal peritoneal exudate cells by administration of Lactobacillus casei.
    Kato I; Yokokura T; Mutai M
    Int J Immunopharmacol; 1985; 7(1):103-9. PubMed ID: 3158616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity.
    Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM
    Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis.
    Sekine K; Ohta J; Onishi M; Tatsuki T; Shimokawa Y; Toida T; Kawashima T; Hashimoto Y
    Biol Pharm Bull; 1995 Jan; 18(1):148-53. PubMed ID: 7537575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.
    Saito M; Ichimura O; Kataoka M; Moriya Y; Ueno K; Sugawara Y; Nanjo M; Ishida N
    Cancer Immunol Immunother; 1986; 22(3):161-8. PubMed ID: 2425968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector mechanism in concomitant immunity potentiated by intratumoral injection of Nocardia rubra cell wall skeleton.
    Ogura T; Hara H; Yokota S; Hosoe S; Kawase I; Kishimoto S; Yamamura Y
    Cancer Res; 1985 Dec; 45(12 Pt 1):6371-5. PubMed ID: 4063987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumoricidal activity of lymphotoxin (tumor necrosis factor beta) in vivo: its effects on macrophages.
    Higuchi M; Mitsuno T; Sugimoto M; Okamoto A; Hirose S; Tsukita S; Osawa T
    J Biol Response Mod; 1988 Dec; 7(6):619-30. PubMed ID: 3265149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors.
    Suzuki T; Tahara H; Narula S; Moore KW; Robbins PD; Lotze MT
    J Exp Med; 1995 Aug; 182(2):477-86. PubMed ID: 7629507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors.
    Nakamura S; Nakata K; Kashimoto S; Yoshida H; Yamada M
    Jpn J Cancer Res; 1986 Aug; 77(8):767-73. PubMed ID: 3093425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant human interleukin 2 on the growth of a BALB/c sarcoma induced by Moloney murine sarcoma virus.
    Mitsunaga S; Kimura H; Yamaguchi Y; Mikata A
    Jpn J Cancer Res; 1988 Aug; 79(8):965-72. PubMed ID: 3141331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of tumor immunity by both CD4+ and CD8+ tumor infiltrating T lymphocytes activated in vivo by IL-2 therapy of tumor bearing mice.
    Maas RA; Becker MJ; Weimar IS; De Nooy JC; Dullens HF; Den Otter WD
    Immunobiology; 1993 Jul; 188(3):281-92. PubMed ID: 7901148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
    Fuyama S; Komatsu H; Arai S
    Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.